Immunohistochemical expression of mTOR negatively correlates with PTEN expression in gastric carcinoma

By            

Oncology Letters, Vol. 4, Iss. 6, 2012-01 ,pp. : 1213-1218

Spandidos Publications

Access to resources Recommend Favorite

Are we missing the mTOR target in breast cancer?

By Johnston Stephen  

Breast Cancer Research and Treatment, Vol. 128, Iss. 3, 2011-08 ,pp. : 607-611

Springer Publishing Company

Access to resources Recommend Favorite

Tendencies for higher co-expression of EGFR and HER2 and downregulation of HER3 in prostate cancer lymph node metastases compared with corresponding primary tumors

By          

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 208-214

Spandidos Publications

Access to resources Recommend Favorite

Synergistic effects of eukaryotic co-expression plasmid-based STAT3-specific siRNA and LKB1 on ovarian cancer in vitro and in vivo

By  

Oncology Reports, Vol. 33, Iss. 2, 2015-01 ,pp. : 774-782

Spandidos Publications

Access to resources Recommend Favorite

Combined inhibition of the EGFR and mTOR pathways in EGFR wild-type non-small cell lung cancer cell lines with different genetic backgrounds

By Huang Yu   Chen Yu   Mei Qin   Chen Yuan   Yu Shiying   Xia Shu  

Oncology Reports, Vol. 29, Iss. 6, 2013-06 ,pp. : 2486-2492

Spandidos Publications

Access to resources Recommend Favorite